Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells.

With the goal of identifying genes that have an expression pattern that can facilitate the diagnosis of primary breast cancers (BCs) as well as the discovery of novel drug leads for BC treatment, we used cDNA hybridization arrays to analyze the gene expression profiles (GEPs) of nine weakly invasive and four highly invasive BC cell lines. Differences in gene expression between weakly and highly invasive BC cells were identified that enabled the definition of consensus GEPs for each invasive phenotype. To determine whether the consensus GEPs, comprising 24 genes, could be used to predict the aggressiveness of previously uncharacterized cells, gene expression levels and comparative invasive and migratory characteristics of nine additional human mammary epithelial cell strains/lines were determined. The results demonstrated that the GEP of a cell line is predictive of its invasive and migratory behavior, as manifest by the morphology of its colonies when cultured on a matrix of basement membrane constituents (i.e., Matrigel). We found that the expression of keratin 19 was consistently elevated in the less aggressive BC cell lines and that vimentin and fos-related antigen-1 (FRA-1) were consistently overexpressed in the more highly aggressive BC cells. Moreover, even without these three genes, the GEP of a cell line still accurately predicted the aggressiveness of the BC cell, indicating that the expression pattern of multiple genes may be used as BC prognosticators because single markers often fail to be predictive in clinical specimens.

[1]  E. Gelmann,et al.  Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells. , 1994, Cancer research.

[2]  Jeffrey M. Skerker,et al.  Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines. , 1992, Cancer research.

[3]  R. Moll,et al.  Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas , 1998, Virchows Archiv.

[4]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[5]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[6]  G. Landes,et al.  Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. , 1999, Cancer research.

[7]  J. McClary,et al.  The novel estrogen-responsive B-box protein (EBBP) gene is tamoxifen-regulated in cells expressing an estrogen receptor DNA-binding domain mutant. , 1998, Molecular endocrinology.

[8]  K. Milde-Langosch,et al.  Expression pattern of the AP‐1 family in breast cancer: Association of fosB expression with a well‐differentiated, receptor‐positive tumor phenotype , 1999, International journal of cancer.

[9]  M J O'Hare,et al.  Linking gene expression patterns to therapeutic groups in breast cancer. , 2000, Cancer research.

[10]  P. Gullino,et al.  Angiogenesis and neoplastic progression in vitro. , 1982, Journal of the National Cancer Institute.

[11]  M. Schena Genome analysis with gene expression microarrays. , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[12]  T. Soussi,et al.  Epithelial HBL-100 cell line derived from milk of an apparently healthy woman harbours SV40 genetic information. , 1985, Experimental cell research.

[13]  E. Gelmann,et al.  Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[14]  G. Martin,et al.  Basement membrane and the invasive activity of metastatic tumor cells. , 1986, Journal of the National Cancer Institute.

[15]  E. Gelmann,et al.  Alterations in β-Catenin Phosphorylation and Plakoglobin Expression in Human Breast Cancer Cells , 1994 .

[16]  R. Weigel,et al.  GATA‐3 is expressed in association with estrogen receptor in breast cancer , 1999, International journal of cancer.

[17]  C. Gilles,et al.  The Epithelial to Mesenchymal Transition and Metastatic Progression in Carcinoma , 1996 .

[18]  P. Brown,et al.  cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype , 1999, Oncogene.

[19]  V. Band,et al.  Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Bittner,et al.  Expression profiling using cDNA microarrays , 1999, Nature Genetics.

[21]  E. Lengyel,et al.  Elevated keratin 18 protein expression indicates a favorable prognosis in patients with breast cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  E. Gelmann,et al.  Regulation of vimentin gene transcription in human breast cancer cell lines. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[23]  G. Laurie,et al.  Basement membrane complexes with biological activity. , 1986, Biochemistry.

[24]  Robert Clarke,et al.  Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines , 1992, Journal of cellular physiology.

[25]  Christian A. Rees,et al.  Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[26]  N. Sampas,et al.  Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.

[27]  J. Price,et al.  Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. , 1990, Cancer research.

[28]  B. Weber,et al.  Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. , 1993, Cancer research.

[29]  R. Sager,et al.  Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor. , 1993, Cancer research.

[30]  M. Johnston,et al.  Gene chips: Array of hope for understanding gene regulation , 1998, Current Biology.

[31]  Jean-Michel,et al.  SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. , 1998, Cancer research.

[32]  H. Nguyen,et al.  Effects of cell cycle, wild-type p53 and DNA damage on p21CIP1/Waf1 expression in human breast epithelial cells. , 1995, Oncogene.

[33]  L. Liotta,et al.  General mechanisms of metastasis , 1997, Cancer.

[34]  S. Ethier,et al.  erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line. , 1996, Cancer research.

[35]  Y Iwamoto,et al.  A rapid in vitro assay for quantitating the invasive potential of tumor cells. , 1987, Cancer research.

[36]  E. Hay An overview of epithelio-mesenchymal transformation. , 1995, Acta anatomica.

[37]  P. Liang,et al.  Identification by differential display of alpha 6 integrin as a candidate tumor suppressor gene , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  M. Hendrix,et al.  Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. , 1997, The American journal of pathology.

[39]  S. Pileri,et al.  DIFFERENTIATION PATHWAYS IN PRIMARY INVASIVE BREAST CARCINOMA AS SUGGESTED BY INTERMEDIATE FILAMENT AND BIOPATHOLOGICAL MARKER EXPRESSION , 1996, The Journal of pathology.

[40]  L. Engel,et al.  Human breast carcinoma cells in continuous culture: a review. , 1978, Cancer research.

[41]  P. Yaswen,et al.  Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[42]  M. Stampfer,et al.  Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[43]  V. Berezin,et al.  Fra-1 Induces Morphological Transformation and Increases In Vitro Invasiveness and Motility of Epithelioid Adenocarcinoma Cells , 1998, Molecular and Cellular Biology.

[44]  M. Bissell,et al.  Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[45]  R. Jove,et al.  Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. , 1997, Cancer research.

[46]  J. Hudson,et al.  In vivo gene expression profile analysis of human breast cancer progression. , 1999, Cancer research.

[47]  O. Kallioniemi,et al.  Molecular cytogenetic analysis of 11 new breast cancer cell lines , 1999, British Journal of Cancer.